🎉 M&A multiples are live!
Check it out!

CurveBeam AI Valuation Multiples

Discover revenue and EBITDA valuation multiples for CurveBeam AI and similar public comparables like Healius, Cyclopharm, and Integral Diagnostics.

CurveBeam AI Overview

About CurveBeam AI

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company’s CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.


Founded

2009

HQ

Australia
Employees

50

Website

curvebeamai.com

Financials

LTM Revenue $6.6M

LTM EBITDA -$7.8M

EV

$29.2M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

CurveBeam AI Financials

CurveBeam AI has a last 12-month revenue of $6.6M and a last 12-month EBITDA of -$7.8M.

In the most recent fiscal year, CurveBeam AI achieved revenue of $4.1M and an EBITDA of -$11.7M.

CurveBeam AI expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See CurveBeam AI valuation multiples based on analyst estimates

CurveBeam AI P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $5.1M $4.1M XXX XXX XXX
Gross Profit $2.5M $2.8M XXX XXX XXX
Gross Margin 50% 67% XXX XXX XXX
EBITDA -$27.4M -$11.7M XXX XXX XXX
EBITDA Margin -540% -285% XXX XXX XXX
Net Profit -$6.0M -$32.2M XXX XXX XXX
Net Margin -119% -785% XXX XXX XXX
Net Debt n/a $5.4M XXX XXX XXX

Financial data powered by Morningstar, Inc.

CurveBeam AI Stock Performance

As of April 15, 2025, CurveBeam AI's stock price is AUD 0 (or $0).

CurveBeam AI has current market cap of AUD 39.0M (or $24.5M), and EV of AUD 46.4M (or $29.2M).

See CurveBeam AI trading valuation data

CurveBeam AI Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$29.2M $24.5M XXX XXX XXX XXX $-0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

CurveBeam AI Valuation Multiples

As of April 15, 2025, CurveBeam AI has market cap of $24.5M and EV of $29.2M.

CurveBeam AI's trades at 4.4x LTM EV/Revenue multiple, and -3.7x LTM EBITDA.

Analysts estimate CurveBeam AI's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for CurveBeam AI and 10K+ public comps

CurveBeam AI Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $29.2M XXX XXX XXX
EV/Revenue 5.1x XXX XXX XXX
EV/EBITDA -3.1x XXX XXX XXX
P/E -1.9x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -2.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get CurveBeam AI Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

CurveBeam AI Valuation Multiples

CurveBeam AI's NTM/LTM revenue growth is 138%

CurveBeam AI's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, CurveBeam AI's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate CurveBeam AI's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for CurveBeam AI and other 10K+ public comps

CurveBeam AI Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -19% XXX XXX XXX XXX
EBITDA Margin -166% XXX XXX XXX XXX
EBITDA Growth -57% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -28% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.3M XXX XXX XXX XXX
S&M Expenses to Revenue 17% XXX XXX XXX XXX
G&A Expenses to Revenue 259% XXX XXX XXX XXX
R&D Expenses to Revenue 12% XXX XXX XXX XXX
Opex to Revenue 413% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

CurveBeam AI Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics and Healthcare Software comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
Integral Diagnostics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

CurveBeam AI M&A and Investment Activity

CurveBeam AI acquired  XXX companies to date.

Last acquisition by CurveBeam AI was  XXXXXXXX, XXXXX XXXXX XXXXXX . CurveBeam AI acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by CurveBeam AI

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About CurveBeam AI

When was CurveBeam AI founded? CurveBeam AI was founded in 2009.
Where is CurveBeam AI headquartered? CurveBeam AI is headquartered in Australia.
How many employees does CurveBeam AI have? As of today, CurveBeam AI has 50 employees.
Is CurveBeam AI publicy listed? Yes, CurveBeam AI is a public company listed on ASX.
What is the stock symbol of CurveBeam AI? CurveBeam AI trades under CVB ticker.
When did CurveBeam AI go public? CurveBeam AI went public in 2023.
Who are competitors of CurveBeam AI? Similar companies to CurveBeam AI include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, Cyclopharm, Healius.
What is the current market cap of CurveBeam AI? CurveBeam AI's current market cap is $24.5M
What is the current revenue of CurveBeam AI? CurveBeam AI's last 12-month revenue is $6.6M.
What is the current EBITDA of CurveBeam AI? CurveBeam AI's last 12-month EBITDA is -$7.8M.
What is the current EV/Revenue multiple of CurveBeam AI? Current revenue multiple of CurveBeam AI is 4.4x.
What is the current EV/EBITDA multiple of CurveBeam AI? Current EBITDA multiple of CurveBeam AI is -3.7x.
What is the current revenue growth of CurveBeam AI? CurveBeam AI revenue growth between 2023 and 2024 was -19%.
Is CurveBeam AI profitable? Yes, CurveBeam AI is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.